ORIGAMI
DEAD

Serial Number

88797477

Owner

Origami Biosciences Inc.

Attorney

Katrin Lewertoff

Filing Date

Feb 14, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ORIGAMI Trademark

Serial Number: 88797477

ORIGAMI is a trademark filed by Origami Biosciences Inc. on February 14, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Origami Biosciences Inc.

Springfield, MA 01115

Entity Type: 03

Trademark Details

Filing Date

February 14, 2020

Registration Date

Not Registered

Published for Opposition

January 12, 2021

Goods & Services

Biotechnological products, namely, bio-chips for scientific purposes

Biotechnological products, namely, diagnostic reagents, medicines for gene therapy for the treatment of genetic diseases and/or cancer for medical purposes; Medicines for treating genetic disorders; Nanoparticles carrying drugs and nucleic acids for treating cancers; Synthetic peptide based nanoparticles for gene therapy for the treatment of genetic diseases and/or cancer; protein-based nanoparticles for gene therapy for the treatment of genetic diseases and/or cancer; cell-based therapeutic products, namely, vaccines; Pharmaceutical compounds for gene therapy for the treatment of genetic diseases and/or cancer; Biological material, namely, biological diagnostic preparations for gene therapy for the treatment of genetic diseases and/or cancer; Nucleic acids for medical purposes; proteins arrays for medical diagnosis purposes; cells for medical use; self-replicating nucleic acids for medical purposes; peptides for gene therapy for the treatment of genetic diseases and/or cancer; Eukaryotic cells for medical purposes; Prokaryotic cells for medical purposes; Stem cells for medical purposes; Living cells for medical purposes; Pharmaceutical compounds for gene therapy for the treatment of genetic diseases and/or cancer, vaccines, diagnostic rubbing compounds for medical purposes; Delivery vehicles, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Reagents for medical purposes; Diagnostic reagents for medicinal use; Bacteria for medical purposes; Diagnostic bacteria for medicinal use; Biochemical compounds for gene therapy for the treatment of genetic diseases and/or cancer for medical and veterinary application; Vaccines for medical and veterinary use

Biotechnological products, namely, chemicals for use in biotechnological product development for scientific purposes; Biological material, namely, biochemical preparations for scientific purposes; Cells for scientific purposes; Eukaryotic cells for scientific purposes; Prokaryotic cells for scientific purposes; Stem cells for scientific purposes; Living cells for scientific purposes; Reagents for scientific purposes; Diagnostic reagents for scientific use; Bacteria for scientific purposes; Diagnostic biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for scientific purposes; Nucleic acid for laboratory use; Proteins for use in manufacture; Small molecules being chemical compounds for use in patterning at nano scale or near nano scale

Consultancy in the field of biotechnology; Research and development in the field of biotechnology; Research and development in the field of immunology; Research and development in the field of biochemistry

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 7, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 7, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 8, 2022 EXRA
SOU EXTENSION 3 GRANTED
Dec 6, 2022 EX3G
SOU EXTENSION 3 FILED
Dec 6, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 6, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2022 EXRA
SOU EXTENSION 2 GRANTED
Jun 24, 2022 EX2G
SOU EXTENSION 2 FILED
Jun 24, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 24, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 1, 2021 EXRA
SOU EXTENSION 1 GRANTED
Nov 29, 2021 EX1G
SOU EXTENSION 1 FILED
Nov 29, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 29, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 6, 2021 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 23, 2021 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 10, 2021 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 12, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jan 12, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 23, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 4, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 2, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 2, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 2, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 2, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 10, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 9, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 9, 2020 TROA
ASSIGNED TO EXAMINER
Jul 27, 2020 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 15, 2020 GNRN
NON-FINAL ACTION E-MAILED
May 15, 2020 GNRT
NON-FINAL ACTION WRITTEN
May 15, 2020 CNRT
ASSIGNED TO EXAMINER
May 6, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 20, 2020 NWOS
NEW APPLICATION ENTERED
Feb 18, 2020 NWAP